Quality

Advanced Modeling Approaches for Bioprocess Data Analysis
Tech & Innovation Advanced Modeling Approaches for Bioprocess Data Analysis

Strategic use of digital shadows allows engineers to run what-if simulations without risking the integrity of a physical production batch during development. This capability marks a dramatic departure from the era when biological manufacturing was as much an art form as it was a science. In the

How Can Digital Twins Enhance Bioprocessing Controls?
Biotech & Bioprocessing How Can Digital Twins Enhance Bioprocessing Controls?

Effective digital twin architecture requires a robust data layer that synchronizes information from SCADA systems and laboratory information management systems. In the current landscape of 2026, the biopharmaceutical industry has moved decisively beyond traditional static modeling toward dynamic,

Can 40°C Optimize Growth for Avian Cultivated Protein?
Biotech & Bioprocessing Can 40°C Optimize Growth for Avian Cultivated Protein?

While 37 degrees Celsius is the global default for biological research, it may actually induce a state of chronic metabolic sluggishness in chicken muscle cells. The emergence of cellular agriculture marks a pivotal shift in how the world approaches food security and sustainable protein, yet the

Why Is Integrated CMC Key to Pharmaceutical Development?
Management & Regulatory Why Is Integrated CMC Key to Pharmaceutical Development?

Modern pharmaceutical development frequently stalls when chemists deliver a bulk powder that formulation scientists cannot effectively process into a stable dosage form. This persistent challenge is largely a relic of outdated, siloed organizational structures where drug substance synthesis and

How Will Fortrea’s Latest Acquisition Impact Your Clinical Trials?
Management & Regulatory How Will Fortrea’s Latest Acquisition Impact Your Clinical Trials?

Phase I Pharmacokinetic studies cannot reach their primary endpoints until bioanalytical data is confirmed as valid across the newly integrated organizational framework. The clinical research landscape shifted significantly with the announcement of Fortrea’s acquisition of Worldwide Clinical

Piramal Pharma Highlights ESG Success in New Sustainability Report
Management & Regulatory Piramal Pharma Highlights ESG Success in New Sustainability Report

Piramal Pharma is currently evaluating 38% of its critical suppliers against strict environmental, social, and governance criteria to ensure sustainability throughout the entire value chain. This initiative represents a fundamental shift in how the pharmaceutical industry approaches procurement,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later